301 related articles for article (PubMed ID: 27466819)
1. Inhibition of Vascular Endothelial Growth Factor Receptor 2 Exacerbates Loss of Lower Motor Neurons and Axons during Experimental Autoimmune Encephalomyelitis.
Stanojlovic M; Pang X; Lin Y; Stone S; Cvetanovic M; Lin W
PLoS One; 2016; 11(7):e0160158. PubMed ID: 27466819
[TBL] [Abstract][Full Text] [Related]
2. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.
Roscoe WA; Welsh ME; Carter DE; Karlik SJ
J Neuroimmunol; 2009 Apr; 209(1-2):6-15. PubMed ID: 19233483
[TBL] [Abstract][Full Text] [Related]
3. Chronic exercise confers neuroprotection in experimental autoimmune encephalomyelitis.
Pryor WM; Freeman KG; Larson RD; Edwards GL; White LJ
J Neurosci Res; 2015 May; 93(5):697-706. PubMed ID: 25510644
[TBL] [Abstract][Full Text] [Related]
4. Motor neuron pathology in experimental autoimmune encephalomyelitis: studies in THY1-YFP transgenic mice.
Bannerman PG; Hahn A; Ramirez S; Morley M; Bönnemann C; Yu S; Zhang GX; Rostami A; Pleasure D
Brain; 2005 Aug; 128(Pt 8):1877-86. PubMed ID: 15901645
[TBL] [Abstract][Full Text] [Related]
5. Oligodendrocyte-specific ATF4 inactivation does not influence the development of EAE.
Yue Y; Stanojlovic M; Lin Y; Karsenty G; Lin W
J Neuroinflammation; 2019 Feb; 16(1):23. PubMed ID: 30709400
[TBL] [Abstract][Full Text] [Related]
6. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis is present in experimental autoimmune encephalomyelitis and pro-angiogenic factors are increased in multiple sclerosis lesions.
Seabrook TJ; Littlewood-Evans A; Brinkmann V; Pöllinger B; Schnell C; Hiestand PC
J Neuroinflammation; 2010 Dec; 7():95. PubMed ID: 21176212
[TBL] [Abstract][Full Text] [Related]
8. PI3Kγ inhibition alleviates symptoms and increases axon number in experimental autoimmune encephalomyelitis mice.
Li H; Park D; Abdul-Muneer PM; Xu B; Wang H; Xing B; Wu D; Li S
Neuroscience; 2013 Dec; 253():89-99. PubMed ID: 24012746
[TBL] [Abstract][Full Text] [Related]
9. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R
J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
[TBL] [Abstract][Full Text] [Related]
10. Enhanced visualization of axonopathy in EAE using thy1-YFP transgenic mice.
Bannerman PG; Hahn A
J Neurol Sci; 2007 Sep; 260(1-2):23-32. PubMed ID: 17493638
[TBL] [Abstract][Full Text] [Related]
11. Deletion of astroglial CXCL10 delays clinical onset but does not affect progressive axon loss in a murine autoimmune multiple sclerosis model.
Mills Ko E; Ma JH; Guo F; Miers L; Lee E; Bannerman P; Burns T; Ko D; Sohn J; Soulika AM; Pleasure D
J Neuroinflammation; 2014 Jun; 11():105. PubMed ID: 24924222
[TBL] [Abstract][Full Text] [Related]
12. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X
Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996
[TBL] [Abstract][Full Text] [Related]
13. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.
Lee CH; Jeon SJ; Cho KS; Moon E; Sapkota A; Jun HS; Ryu JH; Choi JW
Mol Neurobiol; 2018 Apr; 55(4):3007-3020. PubMed ID: 28456941
[TBL] [Abstract][Full Text] [Related]
14. Reduction of a vascular endothelial growth factor receptor, fetal liver kinase-1, by antisense oligonucleotides induces motor neuron death in rat spinal cord exposed to hypoxia.
Shiote M; Nagano I; Ilieva H; Murakami T; Narai H; Ohta Y; Nagata T; Shoji M; Abe K
Neuroscience; 2005; 132(1):175-82. PubMed ID: 15780476
[TBL] [Abstract][Full Text] [Related]
15. Abnormal morphology of myelin and axon pathology in murine models of multiple sclerosis.
Bando Y; Nomura T; Bochimoto H; Murakami K; Tanaka T; Watanabe T; Yoshida S
Neurochem Int; 2015 Feb; 81():16-27. PubMed ID: 25595039
[TBL] [Abstract][Full Text] [Related]
16. Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis.
Vogt J; Paul F; Aktas O; Müller-Wielsch K; Dörr J; Dörr S; Bharathi BS; Glumm R; Schmitz C; Steinbusch H; Raine CS; Tsokos M; Nitsch R; Zipp F
Ann Neurol; 2009 Sep; 66(3):310-22. PubMed ID: 19798635
[TBL] [Abstract][Full Text] [Related]
17. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.
Berard JL; Wolak K; Fournier S; David S
Glia; 2010 Mar; 58(4):434-45. PubMed ID: 19780195
[TBL] [Abstract][Full Text] [Related]
18. Loss of Nrf2 exacerbates the visual deficits and optic neuritis elicited by experimental autoimmune encephalomyelitis.
Larabee CM; Desai S; Agasing A; Georgescu C; Wren JD; Axtell RC; Plafker SM
Mol Vis; 2016; 22():1503-1513. PubMed ID: 28050123
[TBL] [Abstract][Full Text] [Related]
19. Developmental endothelial locus-1 is a homeostatic factor in the central nervous system limiting neuroinflammation and demyelination.
Choi EY; Lim JH; Neuwirth A; Economopoulou M; Chatzigeorgiou A; Chung KJ; Bittner S; Lee SH; Langer H; Samus M; Kim H; Cho GS; Ziemssen T; Bdeir K; Chavakis E; Koh JY; Boon L; Hosur K; Bornstein SR; Meuth SG; Hajishengallis G; Chavakis T
Mol Psychiatry; 2015 Jul; 20(7):880-888. PubMed ID: 25385367
[TBL] [Abstract][Full Text] [Related]
20. Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis.
Wujek JR; Bjartmar C; Richer E; Ransohoff RM; Yu M; Tuohy VK; Trapp BD
J Neuropathol Exp Neurol; 2002 Jan; 61(1):23-32. PubMed ID: 11829341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
